• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23373 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Tocolysis in preterm labour - a systematic review of evidence-based guidelines, effectiveness and health economic evaluations
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009     University of York Physical health monitoring for people with schizophrenia or other serious mental illness
2009     Penn Medicine Center for Evidence-based Practice (CEP) Hybrid revascularization
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins: review of the comparative effectiveness for various indications
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009     Agenzia nazionale per i servizi sanitari regionali (Agenas) Technologies for the identification of osteoporosis
2009     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for surgical pain management
2009     HAYES, Inc. Combining multislice computed tomography imaging with electroanatomic mapping to guide radiofrequency catheter ablation procedures for atrial fibrillation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Specialty mattresses for the prevention and management of pressure ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Agenzia nazionale per i servizi sanitari regionali (Agenas) Prostheses for primary total knee replacement in Italy
2009     Belgian Health Care Knowledge Centre (KCE) Use of point-of care devices in patients with oral anticoagulation: a health technology assessment
2009     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for bariatric surgery
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Artificial food colours and hyperactivity
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2009     Penn Medicine Center for Evidence-based Practice (CEP) Prevention of surgical site infections
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     Agency for Health Technology Assessment in Poland (AHTAPol) Clinical effectiveness analysis of bosentan, epoprostenol, iloprost, sildenafil and treprostinil in treatment of pulmonary arterial hypertension: a systematic review of randomised controlled trials
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     HAYES, Inc. Computerized provider order entry for medications: adult inpatients
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Descemet stripping automated endothelial keratoplasty: a review of the clinical and cost-effectiveness
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Clinical practice guideline on eating disorders
2009     HAYES, Inc. Craniosacral therapy
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Nonmedical secondary prevention of patients with coronary heart disease]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for autism: a review of the clinical and cost-effectiveness
2009     VA Technology Assessment Program (VATAP) Health risks from cellular phone use
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Arthroplasty register for Germany]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Casting for foot orthotics: a review of the clinical and cost-effectiveness
2009     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Smoking cessation among patients in general practice - a health technology assessment]
2009     HAYES, Inc. 3.0 Tesla (3T) Magnetic Resonance Imaging (MRI) for Prostate Cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for mood disorders: a review of the clinical effectiveness
2009     National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of relapsed small-cell lung cancer. NICE technology appraisal guidance 184
2009     HAYES, Inc. Echinacea for prevention or treatment of the common cold
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Age-related macular degeneration: the role of current treatment strategies]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adults with axis II disorders: a review of clinical effectiveness
2009     National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of recurrent and stage IVB cervical cancer. NICE technology appraisal guidance 183
2009     Penn Medicine Center for Evidence-based Practice (CEP) Allen test for predicting complications from arterial cannulation
2009     VA Technology Assessment Program (VATAP) Systematic reviews for podiatry
2009     Institute for Clinical Evaluative Sciences (ICES) Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for anxiety: a review of the clinical effectiveness
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2009     Agency for Healthcare Research and Quality (AHRQ) Use of Bayesian techniques in randomized clinical trials: a CMS case study
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2009     Penn Medicine Center for Evidence-based Practice (CEP) IV injection sites for post-mastectomy patients
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Amotosalen (Intercept) for the inactivation of pathogens for transfusion therapy]
2009     VA Technology Assessment Program (VATAP) Systematic reviews for amyotrophic lateral sclerosis
2009     Institute for Clinical Evaluative Sciences (ICES) What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy in the treatment of schizophrenia: a review of the clinical effectiveness
2009     National Institute for Health and Care Excellence (NICE) Sunitinib for the treatment of gastrointestinal stromal tumours. NICE technology appraisal guidance 179
2009     Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009     Penn Medicine Center for Evidence-based Practice (CEP) IV placement in chronic kidney disease patients
2009     Blue Cross Blue Shield Association (BCBS) CT colonography (virtual colonoscopy) for colon cancer screening
2009     The Swedish Council on Health Technology Assessment (SBU) [How can drug consumption among the elderly be improved?]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Angiographic profile of patients undergoing drug eluting stent implantation in Spain. Variability of off-label indications]
2009     VA Technology Assessment Program (VATAP) Systematic reviews for nurse-led primary care
2009     Institute for Clinical Evaluative Sciences (ICES) Registry of the Canadian Stroke Network. Report on the 2004/05 Ontario Stroke Audit
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pathogen reduction technologies for blood products: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     National Institute for Health and Care Excellence (NICE) Pemetrexed for the first-line treatment of non-small-cell lung cancer. NICE technology appraisal guidance 181
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Medical and health economic assessment of radiosurgery for the treatment of brain metastasis]
2009     Penn Medicine Center for Evidence-based Practice (CEP) Prevention of ventilator-associated pneumonia
2009     Blue Cross Blue Shield Association (BCBS) Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Artificial liver support systems]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     National Institute for Health and Care Excellence (NICE) Alitretinoin for the treatment of severe chronic hand eczema. NICE technology appraisal guidance 177
2009     Penn Medicine Center for Evidence-based Practice (CEP) Prevention and management of delirium
2009     HAYES, Inc. Endoscopic retrograde cholangiopancreatography for the treatment of benign and malignant diseases of the pancreas and biliary tree
2009     Blue Cross Blue Shield Association (BCBS) Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009     VA Technology Assessment Program (VATAP) Regionalization of surgical services
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009     National Institute for Health and Care Excellence (NICE) Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 178
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Reuse of single use medical devices]
2009     Agency for Healthcare Research and Quality (AHRQ) Horizon Scan: to what extent do changes in third-party payment affect clinical trials and the evidence base
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Prostacyclins (epoprostenol, iloprost, treprostinil and beraprost) for the management of primary pulmonary hypertension and pulmonary hypertension in collagen vascular disease
2009     HAYES, Inc. Endovenous laser therapy for varicose veins due to great saphenous vein reflux
2009     Blue Cross Blue Shield Association (BCBS) Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2009     HAYES, Inc. Nanoparticle-based cancer therapies: Albumin-bound paclitaxel
2009     VA Technology Assessment Program (VATAP) Simulation training
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009     National Institute for Health and Care Excellence (NICE) Tenofovir disoproxil for the treatment of chronic hepatitis B. NICE technology appraisal guidance 173
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Effects and costs of a combined screening and treatment program for elderly (aged 75 years and over) with depressive symptoms in general practice]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Behavioural and skill-based early interventions in children with autism spectrum disorders]
2009     HAYES, Inc. Endovenous laser therapy for varicose veins due to small saphenous vein reflux
2009     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Defibrillators in public places]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009     National Institute for Health and Care Excellence (NICE) Rituximab for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 174
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of a shared knowledge system for network assessment of technological innovation in medicine]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009     National Institute for Health and Care Excellence (NICE) Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. NICE technology appraisal guidance 170
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of the Australian medical sheepskin for the prevention of pressure ulcers in somatic nursing home clients]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness and cost-efficiency of phosphate binders in hemodialysis]